NextCure logo
NextCure NXTC
$ 1.21 -6.2%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

NextCure Balance Sheet 2011-2024 | NXTC

Annual Balance Sheet NextCure

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-6.48 M -19.5 M - -29.3 M -29.1 M -135 M -7.57 M - - - - - -

Long Term Debt

5.95 M 6.6 M - 1.81 M 3.33 M 73 K 460 K - - - - - -

Long Term Debt Current

656 K 518 K - 1.67 M 1.67 M - - - - - - - -

Total Non Current Liabilities

- - - 2.6 M - 184 M 40.8 M - - - - - -

Total Current Liabilities

6.88 M 9.13 M 6.61 M 10.3 M 15 M - - - - - - - -

Total Liabilities

13.6 M 16.6 M 9 M 12.9 M 34.7 M 195 M 43.9 M - - - - - -

Deferred Revenue

- - - - - 4.99 M - - - - - - -

Retained Earnings

-324 M -262 M -187 M -118 M -81 M -47.3 M -24.5 M - - - - - -

Total Assets

128 M 184 M 242 M 307 M 356 M 148 M 19.5 M - - - - - -

Cash and Cash Equivalents

13.1 M 26.6 M 12.3 M 32.8 M 34.1 M 136 M - - - - - - -

Book Value

114 M 168 M 233 M 294 M 321 M -46.9 M -24.4 M - - - - - -

Total Shareholders Equity

114 M 168 M 233 M 294 M 321 M -46.9 M - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet NextCure

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

5.39 M 5.59 M 5.77 M 5.95 M 6.12 M 6.29 M 6.45 M 6.6 M - - - - - 972 K 1.39 M 1.81 M 1.81 M 1.81 M 1.81 M 3.33 M 3.33 M 3.33 M 3.33 M 73 K 73 K 73 K 73 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

14.8 M 17.1 M 16.1 M 13.6 M 13.5 M 15 M 13.6 M 16.6 M 8.37 M - 8.81 M 9 M 9.6 M 11.8 M 11.8 M 12.9 M 12.9 M 12.9 M 12.9 M 34.7 M 34.7 M 34.7 M 34.7 M 32.3 M 32.3 M 32.3 M 32.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-369 M -357 M -342 M -324 M -310 M -296 M -278 M -262 M -244 M - -208 M -187 M -170 M -152 M -134 M -118 M -118 M -118 M -118 M -81 M -81 M -81 M -81 M -47.3 M -47.3 M -47.3 M -47.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

90.3 M 103 M 115 M 128 M 140 M 153 M 168 M 184 M 190 M - 223 M 242 M 258 M 275 M 291 M 307 M 307 M 307 M 307 M 356 M 356 M 356 M 356 M 148 M 148 M 148 M 148 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

27.7 M 20.8 M 18.4 M 13.1 M 19.5 M 22 M 30 M 26.6 M 31.1 M 28.2 M 10.7 M 12.3 M 36.7 M 34.9 M 36.5 M 32.8 M 32.8 M 32.8 M 32.8 M 34.1 M 34.1 M 34.1 M 34.1 M 135 M 135 M 135 M 135 M 9.29 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

75.6 M 85.4 M 99 M 114 M 126 M 138 M 154 M 168 M 182 M - 214 M 233 M 248 M 264 M 279 M 294 M 294 M 294 M 294 M 321 M 321 M 321 M 321 M 115 M 115 M 115 M 115 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

75.6 M 85.4 M 99 M 114 M 126 M 138 M 154 M 168 M 182 M 198 M 214 M 233 M 248 M 264 M 279 M 294 M 294 M 294 M 294 M 321 M 321 M 321 M 321 M -46.9 M -46.9 M -46.9 M -46.9 M -24.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency